亚苄基山梨醇衍生物在有机溶剂中的自组装及凝胶化研究

从分子结构的差异、亲溶剂作用、分子几何构型、相转变热焓以及溶剂极性等方面研究了三种亚苄基山梨醇衍生物凝胶剂在有机溶剂中的自组装和凝胶化机理. 三种衍生物凝胶剂在结构上的差别仅在于亚苄基上甲基取代基数量不同. 结果表明: 由于亲溶剂作用的增加和分子几何构型的优化, 含甲基多的凝胶剂在有机溶剂中的自组装能力强, 表现在具有低的最低凝胶化浓度和高的相转变温度. 而溶剂极性的增强, 使三种衍生物凝胶剂形成的凝胶相转变温度降低. 偏光显微镜照片表明该凝胶剂在正辛醇凝胶中的聚集体晶型不同. 场发射扫描电镜照片表明三种衍生物凝胶剂自组装形成相互缠绕的纤维束网络结构. 紫外吸收光谱表明, 对比其溶液态, 三种衍生物聚集体苯环的K带发生红移, 表明π-π堆积作用是亚苄基山梨醇衍生物凝胶剂自组装的驱动力之一; 红移的幅度随苯环上甲基数量的增加而增加, 这与三种衍生物形成的分子凝胶的热稳定性相吻合.     

π-共轭三苯基苯衍生物的合成及其胶凝性能

合成了一系列三单脂肪链具有盘状结构的三苯基苯衍生物并研究了其在有机溶剂中自组装行为. 结果表明, 该系列衍生物在多种低极性有机溶剂中可以形成稳定的凝胶, 利用小角X射线衍射实验和扫描电子显微镜技术观察到干凝胶的分子排列具有层状结构, 形成纤维状和片层状聚集, 紫外-可见吸收光谱和红外光谱结果表明分子间氢键和π-π共轭堆积效应是形成自组装凝胶的主要驱动力. 在形成凝胶过程中, 凝胶剂分子在溶液中通过盘状中心的π-π共轭堆积效应和酰胺键的分子间氢键作用自组装成层状结构, 层状结构进一步组装形成纤维状和片层状聚集体, 最终形成三维网状结构阻碍溶剂流动形成凝胶.     

固相合成法制备组氨酸-苯丙二肽分子及其自组装研究

本文以组装性能良好的苯丙氨酸二肽(FF)为母体分子,用组氨酸对其进行化学修饰,通过多肽固相合成法合成了组氨酸-苯丙二肽(HisFF)凝胶因子。合成的HisFF分子通过质谱、核磁氢谱和液相色谱等确定其精确结构和纯度。通过透射电镜和扫描电镜观察HisFF聚集体的形貌结构。HisFF分子在甲苯、氯仿和乙酸乙酯溶剂中形成的凝胶的强度不同,透射电镜实验结果表明纤维强度和聚集形态也影响其凝胶的强度。通过不同组装方法,HisFF可以在多种溶剂中组装成各种各样的纳米结构。例如,HisFF在丙酮、甲醇和乙酸乙酯溶剂中可组装成纳米颗粒、纳米管和螺旋状纳米纤维;HisFF先经六氟异丙醇溶解再通过溶剂稀释后,可得到不同直径的纳米纤维。     

固相合成法制备组氨酸-苯丙二肽及其自组装研究

本文以组装性能良好的苯丙氨酸二肽(FF)为母体分子,用组氨酸对其进行化学修饰,通过多肽固相合成法合成了组氨酸-苯丙二肽(HisFF)凝胶因子。合成的HisFF分子通过质谱(MS)、核磁共振(NMR)和液相色谱(HPLC)方法测试确定精确的结构和纯度。HisFF聚集体的形貌结构通过透射电子显微镜(TEM)和扫描电子显微镜(SEM)观察。HisFF分子在甲苯、氯仿和乙酸乙酯溶剂中形成凝胶强度不同,TEM实验结果表明纤维强度和聚集形态影响其凝胶的强度。组氨酸-苯丙二肽在多种溶剂中,通过不同组装方法可以组装成各种各样的纳米结构。例如,HisFF在丙酮、甲醇和乙酸乙酯溶剂中可组装成纳米颗粒、纳米管和螺旋状纳米纤维;组氨酸-苯丙二肽先经HFIP溶解再通过溶剂稀释后,可得到不同直径的纳米纤维。但是在四氢呋喃、乙醇和乙腈溶剂中,两种方法组装的形貌几乎无变化。     

4,4′-二(硬脂酰胺基)二苯甲烷在乙烯基类单体中的分子组装及其结构形态研究

4,4′-二(硬脂酰胺基)二苯甲烷(BSDM)能在乙烯基类单体中进行聚集、自组装,并可使苯乙烯、丙烯酸丁酯、甲基丙烯酸甲酯、甲基丙烯酸-2-羟基乙酯等凝胶化,形成相应的分子凝胶.凝胶/溶胶相变温度(TGS)与BSDM浓度有关,BSDM质量分数越大,凝胶体系中分子间氢键和π-π键越多,要破坏它们所需要的能量越高,TGS因而也就越高.透射电镜表明,BSDM在各种可聚合溶剂中通过分子间相互作用形成类似纤维状的聚集体结构.BSDM在可聚合溶剂聚合前后的偏光显微照片表明,BSDM在体系中的晶型结构是球晶.     

4,4′-二(硬脂酰胺基)二苯甲烷在乙烯基类单体中的分子组装及其结构形态研究

4,4′-二(硬脂酰胺基)二苯甲烷(BSDM)能在乙烯基类单体中进行聚集、自组装,并可使苯乙烯、丙烯酸丁酯、甲基丙烯酸甲酯、甲基丙烯酸-2-羟基乙酯等凝胶化,形成相应的分子凝胶.凝胶/溶胶相变温度(TGS)与BSDM浓度有关,BSDM质量分数越大,凝胶体系中分子间氢键和π-π键越多,要破坏它们所需要的能量越高,TGS因而也就越高.透射电镜表明,BSDM在各种可聚合溶剂中通过分子间相互作用形成类似纤维状的聚集体结构.BSDM在可聚合溶剂聚合前后的偏光显微照片表明,BSDM在体系中的晶型结构是球晶.     

L-苯丙氨酸衍生物与脂肪胺构筑双组分超分子凝胶

设计合成了系列单链L-苯丙氨酸衍生物,该系列衍生物单组分没有胶凝性能.选择脂肪胺作为配对物,与L-苯丙氨酸衍生物组成双组分体系后能够胶凝许多有机溶剂形成凝胶.流变学测试显示该凝胶体系弹性模量(G′)比粘性模量(G′′)约高一个数量级,有着很好的机械性能,并且呈现出典型的类固体的流变学行为.傅里叶变换红外(FT-IR)光谱、核磁共振(NMR)谱、小角X射线衍射(SAXS)和扫描电镜(SEM)结果表明,凝胶中胶凝剂分子形成纤维状或片层状的聚集体,羧基(―COOH)和氨基(―NH2)的酸碱作用、酰胺基团间(―CONH―)的氢键作用以及分子间范德华作用力是形成该凝胶的主要驱动力.凝胶中胶凝剂分子自组装形成具有周期性的层状有序结构,层状结构进一步组装形成纤维状聚集体,最终形成三维网状结构阻碍溶剂流动形成凝胶.     

纳米生物界面对淀粉样蛋白聚集的调控机制研究

本文以阿尔兹海默症的致病多肽β淀粉样蛋白(Aβ)为例,介绍了疾病相关淀粉样蛋白的分子精细结构、组装和聚集过程、聚集体形貌及神经细胞毒性的研究进展,并在此基础上以纳米生物界面对于淀粉样蛋白构象、组装结构、聚集动力学、神经细胞毒性等生物功能的调控机制进行研究.从分子水平上分析和探讨了纳米生物界面与淀粉样蛋白分子或者聚集体的相互作用方式和机理,有助于加深对淀粉样多肽和调节剂之间复杂多样的相互作用方式的理解,对深入了解淀粉样多肽的组装机理和调控机制以及探索治疗神经退行性疾病的药物设计等方面具有较大意义.     

反应型凝胶剂2,4-二烷脲基甲苯衍生物及有机溶剂的室温凝胶化研究

通常制备有机分子凝胶是在高温下溶解凝胶剂,凝胶剂分子在冷却过程中进行自组装并使有机溶剂凝胶化.该方法限制了某些低沸点溶剂的凝胶化.利用甲苯二异氰酸酯与烷基胺的高反应活性,制备了3种反应型凝胶剂.这种反应型凝胶剂能以较低的浓度在室温下使某些芳香族和卤代烃溶剂形成热可逆的有机分子凝胶.场发射扫描电镜表明这种反应型凝胶剂在有机溶剂中自组装形成纤维状三维网络结构.随着烷基胺中的烷基链长度不同,形成的纤维状聚集体的形态也不同.FT-IR和1H NMR研究表明分子间氢键作用是反应型凝胶剂自组装的驱动力.通过XRD和分子模拟推测了其聚集体的结构形态.     

L-苯丙氨酸衍生物与脂肪胺构筑双组分超分子凝胶

设计合成了系列单链L-苯丙氨酸衍生物,该系列衍生物单组分没有胶凝性能. 选择脂肪胺作为配对物,与L-苯丙氨酸衍生物组成双组分体系后能够胶凝许多有机溶剂形成凝胶. 流变学测试显示该凝胶体系弹性模量（G’）比粘性模量（G"）约高一个数量级,有着很好的机械性能,并且呈现出典型的类固体的流变学行为. 傅里叶变换红外（FT-IR）光谱、核磁共振（NMR）谱、小角X射线衍射（SAXS）和扫描电镜（SEM）结果表明,凝胶中胶凝剂分子形成纤维状或片层状的聚集体,羧基（―COOH）和氨基（―NH₂）的酸碱作用、酰胺基团间（―CONH―）的氢键作用以及分子间范德华作用力是形成该凝胶的主要驱动力. 凝胶中胶凝剂分子自组装形成具有周期性的层状有序结构,层状结构进一步组装形成纤维状聚集体,最终形成三维网状结构阻碍溶剂流动形成凝胶.     

二氧化碳和丙烯直接合成甲基丙烯酸的NiPMo/TiO2催化剂的研究

用溶胶-凝胶法以磷钼酸(MPA)的镍盐溶液水解钛酸四丁酯制备了NiPMo/TiO2催化剂.使用ICP、 XRD、 TG-DTA、 IR、 TPD-MS和微反应技术研究了催化剂的化学组成、热稳定性、化学吸附性质和催化反应性能.杂多钼酸盐与TiO2通过O2-在TiO2表面发生了键合.在623 K下,杂多阴离子仍保持原有的Keggin结构.CO2在Lewis酸位Ni(Ⅱ)和Lewis碱位Ni-O-Mo的桥氧协同作用下生成CO2卧式吸附态Ni(Ⅱ)←O-(CO)←(O--Ni).丙烯有多种吸附态在催化剂上吸附.在563 K、 1 MPa和空速1500 h-1的反应条件下,丙烯的摩尔转化率为3.2%,产物MAA选择性为95%.     

Synthesis of 1-benzyloxypyrazin-2(1H)-one derivatives

Different approaches for the synthesis of 1-benzyloxypyrazin-2(1H)-one derivatives from simple amino acids have been investigated. A library of 33 precursors for the preparation of N-hydroxy pyrazinones was obtained in moderate to good yields.     

α-Amino acid derived enaminones and their application in the synthesis of N-protected methyl 5-substituted-4-hydroxypyrrole-3-carboxylates and other heterocycles

A new and simple synthesis of novel N-protected methyl 5-substituted-4-hydroxypyrrole-3-carboxylates, which exist in equilibrium with their 4-oxo tautomers, has been developed in two steps starting from N-protected α-amino acids. The key intermediates are enaminones, which can also be isolated, characterized, and used for the construction of other functionalized heterocycles, before they spontaneously decompose to pyrrole products. 4-Hydroxypyrroles are prone to partial aerial oxidation but can be efficiently alkylated or reduced to stable polysubstituted pyrrolidine derivatives.     

Specific intramolecular aromatic CH insertion of diazosulfonamides

The chemoselectivity in the intramolecular CH insertion of various diazosulfonamides has been experimentally studied. The results reveal that the aliphatic 1,4-, 1,5-, or 1,6-C(sp³)?H insertions of diazosulfonamides are not accessible, while the aromatic 1,5-C(sp²)?H insertion can be realized specifically by adjusting the diazo-adjacent group. In addition, the general chemoselectivities in the intramolecular CH insertions of diazosulfonyl compounds are summarized. Generally, diazosulfones undergo both aromatic 1,5-C(sp²)?H and aliphatic 1,5- and 1,6-C(sp³)?H insertions, while diazosulfonates undergo aliphatic 1,5- and 1,6-C(sp³)?H insertions. However, diazosulfonamides only undergo aromatic 1,5-C(sp²)?H insertion.     

A general and convenient synthesis of 4-(tosylmethyl)semicarbazones and their use in amidoalkylation of hydrogen,heteroatom, and carbon nucleophiles

A general synthesis of previously unknown semicarbazone-based α-amidoalkylating reagents, 4-(tosylmethyl)semicarbazones, has been developed. The synthesis involved three-component condensation of semicarbazones of aliphatic or aromatic aldehydes with the same or other aldehydes and p-toluenesulfinic acid. The scope and limitations of this reaction were investigated. The compounds obtained were demonstrated to be an efficient α-(4-semicarbazono)alkylating agents. They were reacted with H- (sodium borohydride), O- (sodium methylate), S- (sodium phenylthiolate), N- (pyrrolidine, sodium succinimide), P- (trialkyl phosphites), and C-nucleophiles (sodium diethyl malonate) to give the corresponding products of the tosyl group substitution, 4-substituted semicarbazones, including analogues of nitrofurazone. Among the prepared compounds tested in vitro for antibacterial and antifungal activity, three nitrofuryl-containing semicarbazones exhibited high biological activities with minimum inhibitory concentration (MIC) values of 8–32 μg/mL.     

Toward new camptothecins. Part 6: Synthesis of crucial ketones and their use in Friedländer reaction

In the context of the preparation of camptothecin and luotonin A analogs, the synthesis of some key keto-precursors and their use in Friedländer condensation are described. This paper also focuses on the stability of these keto intermediates and emphasizes the major differences between indolizinones and pyrroloquinazolinones series. Noteworthy is also the report of some original structures isolated as by-products of some experiments.     

Synthesis of novel chiral bidentate hydroxyalkyl-N-heterocyclic carbene ligands and their application in palladium-catalyzed Mizoroki–Heck couplings and asymmetric addition of diethylzinc to benzaldehyde

A small library of new chiral bidentate hydroxyalkyl-imidazolium salts 1 is conveniently synthesized on multi-gram scale from inexpensive and commercially available chiral pool amino acids. The corresponding carbenes, generated by deprotonation of imidazolium salts 1, in combination with palladium(II) chloride were tested in the Mizoroki–Heck coupling reaction. The most significant results in terms of yields and reactivities were achieved with low catalyst loading. The catalytic activities of these imidazolium salts were also investigated in the asymmetric addition of diethylzinc to benzaldehyde. The use of MgO nanoparticles as an additive in conjunction with these ligands played a crucial role in increasing the efficiency of these reactions.     

N-Heterocyclic carbene-palladacyclic complexes: synthesis,characterization and their applications in the C-N coupling and α-arylation of ketones using aryl chlorides

N-Heterocyclic carbene-palladacyclic complexes 3 were successfully achieved in a one-pot procedure under mild conditions. The structure of 3a was unambiguously confirmed by X-ray single crystal diffraction and it was an active catalyst in the Buchwald-Hartwig amination and α-arylation of ketones even at very low catalyst loadings (0.01?mol%).     

Iodine-mediated oxidative Pictet-Spengler reaction using terminal alkyne as the 2-oxoaldehyde surrogate for the synthesis of 1-aroyl-β-carbolines and fused-nitrogen heterocycles

An efficient iodine-mediated oxidative Pictet-Spengler reaction in dimethyl sulphoxide (DMSO) using terminal alkynes as the 2-oxoaldehyde surrogate for the synthesis of aryl (9H-pyrido[3,4-b]indol-1-yl)methanones is described. The scope of the protocol includes the total synthesis of Fascaplysin, Eudistomins Y₁ and Y₂. The methodology is extended for preparing pyrrolo[1,2-a]-quinoxaline and indolo[1,5-a]quinoxaline derivatives. The utility of 1-aroyl-β-carbolines was demonstrated by performing palladium-catalyzed β-carboline directed ortho-C(sp2)-H functionalization of the phenyl ring with thiomethyl (SMe) group using DMSO as source and for accessing 4-aryl-canthin-6-ones.     

Facile synthesis of bicyclic 1-arylpyrazol-5-ones

In this Letter, we described a facile method for constructing fused bicyclic 1-arylpyrazol-5-one ring system. We employed various methylene-containing carboxylic acids as the substrates and proved that the pyrazolone ring closure requires activated methylene group in intermediate II. Accordingly, a series of structurally diversified, fused bicyclic 1-arylpyrazol-5-ones was prepared in moderate to high yields using the requisite substrates.